<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35893072</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1336</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13081336</ELocationID><Abstract><AbstractText>Objective: To investigate the association of different, selected pain polymorphisms with the presence of de novo long-COVID pain symptoms and to analyze the association between these polymorphisms with clinical, sensory-related, cognitive and psychological variables in COVID-19 survivors. Methods: Two hundred and ninety-three (n = 293, 49.5% female, mean age: 55.6 &#xb1; 12.9 years) previously hospitalized COVID-19 survivors participated. Three genotypes of the following single nucleotide polymorphisms (SNPs) were obtained from non-stimulated saliva: OPRM1 (rs1799971), COMT (rs4680), BDNF (rs6265), and HTR1B (rs6296) by polymerase chain reactions in all participants. Further, clinical (intensity/duration of pain), sensory-related (sensitization-associated symptoms, neuropathic pain features), psychological (anxiety or depressive levels, sleep quality), and cognitive (catastrophizing, kinesiophobia) variables were collected in those COVID-19 survivors suffering from post-COVID pain. Analyses were carried out to associate clinical features with genotype. Results: Participants were assessed 17.8 &#xb1; 5.2 months after hospitalization. One hundred and seventeen (39.9%) experienced post-COVID pain (particularly of musculoskeletal origin). The distributions of the genotype variants of any SNP were not significantly different between COVID-19 survivors with and without long-term post-COVID pain (all, p &gt; 0.178). No differences in sensitization-associated symptoms, neuropathic pain features, catastrophizing, kinesiophobia levels, anxiety and depressive levels or sleep quality according to the genotype variant in any SNPs were found. No effect of gender was identified. Conclusion: The four SNPs generally associated with pain did not appear to predispose to the development of de novo long-COVID pain symptoms in previously hospitalized COVID-19 survivors. The SNPs were not involved in the phenotypic features of post-COVID pain either.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Gil</LastName><ForeName>Gema</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3480-1490</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Crujera</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1022-5831</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-7140-4286</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambite-Quesada</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6755-8189</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009437" MajorTopicYN="Y">Neuralgia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">risk</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35893072</ArticleId><ArticleId IdType="pmc">PMC9394327</ArticleId><ArticleId IdType="doi">10.3390/genes13081336</ArticleId><ArticleId IdType="pii">genes13081336</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Delanghe J.R., de Buyzere M.L., Speeckaert M.M. Genetic Polymorphisms in the Host and COVID-19 Infection. Adv. Exp. Med. Biol. 2021;1318:109&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">33973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Adli A., Rahimi M., Khodaie R., Hashemzaei N., Hosseini S.M. Role of genetic variants and host polymorphisms on COVID-19: From viral entrance mechanisms to immunological reactions. J. Med. Virol. 2022;94:1846&#x2013;1865. doi: 10.1002/jmv.27615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27615</ArticleId><ArticleId IdType="pmc">PMC9015257</ArticleId><ArticleId IdType="pubmed">35076118</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a Arendt-Nielsen L. Time course prevalence of Post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulkes T., Wood J.N. Pain genes. PLoS Genet. 2008;4:e1000086. doi: 10.1371/journal.pgen.1000086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000086</ArticleId><ArticleId IdType="pmc">PMC2432024</ArticleId><ArticleId IdType="pubmed">18654615</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossen H., Kenis G., Rutten B., van Os J., Hermens H., Lousberg R. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS ONE. 2010;5:e13641. doi: 10.1371/journal.pone.0013641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013641</ArticleId><ArticleId IdType="pmc">PMC2964315</ArticleId><ArticleId IdType="pubmed">21049025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tour J., L&#xf6;fgren M., Mannerkorpi K., Gerdle B., Larsson A., Palstam A., Bileviciute-Ljungar I., Bjersing J., Martin I., Ernberg M., et al. Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes. Pain. 2017;158:1194&#x2013;1203. doi: 10.1097/j.pain.0000000000000896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000896</ArticleId><ArticleId IdType="pmc">PMC5472004</ArticleId><ArticleId IdType="pubmed">28282362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei S.Y., Chao H.T., Tu C.H., Lin M.W., Li W.C., Low I., der Shen H., Chen L.F., Hsieh J.C. The BDNF Val66Met polymorphism is associated with the functional connectivity dynamics of pain modulatory systems in primary dysmenorrhea. Sci. Rep. 2016;6:23639. doi: 10.1038/srep23639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23639</ArticleId><ArticleId IdType="pmc">PMC4806293</ArticleId><ArticleId IdType="pubmed">27010666</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter C., Doehring A., Oertel B.G., L&#xf6;tsch J. &#xb5;-opioid receptor gene variant OPRM1 118 A&gt;G: A summary of its molecular and clinical consequences for pain. Pharmacogenomics. 2013;14:1915&#x2013;1925. doi: 10.2217/pgs.13.187.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/pgs.13.187</ArticleId><ArticleId IdType="pubmed">24236490</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingim R.B., Kaplan L., Staud R., Ness T.J., Glover T.L., Campbell C.M., Mogil J.S., Wallace M.R. The A118G single nucleotide polymorphism of the &#x3bc;-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J. Pain. 2005;6:159&#x2013;167. doi: 10.1016/j.jpain.2004.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2004.11.008</ArticleId><ArticleId IdType="pubmed">15772909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambur O., M&#xe4;nnist&#xf6; P.T. Catechol-O-Methyltransferase and pain. Int. Rev. Neurobiol. 2010;95:227&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">21095465</ArticleId></ArticleIdList></Reference><Reference><Citation>Belfer I., Segall S. COMT genetic variants and pain. Drugs Today. 2011;47:457&#x2013;467. doi: 10.1358/dot.2011.47.6.1611895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1358/dot.2011.47.6.1611895</ArticleId><ArticleId IdType="pubmed">21695287</ArticleId></ArticleIdList></Reference><Reference><Citation>Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Goldman D., Xu K., Shabalina S.A., Shagin D., et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 2005;14:135&#x2013;143. doi: 10.1093/hmg/ddi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi013</ArticleId><ArticleId IdType="pubmed">15537663</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammim&#xe4;ki A., M&#xe4;nnist&#xf6; P.T. Catechol-O-methyltransferase gene polymorphism and chronic human pain: A systematic review and meta-analysis. Pharmacogenet. Genomics. 2012;22:673&#x2013;691. doi: 10.1097/FPC.0b013e3283560c46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FPC.0b013e3283560c46</ArticleId><ArticleId IdType="pubmed">22722321</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.B., Maixner D.W., Greenspan J.D., Dubner R., Fillingim R.B., Ohrbach R., Knott C., Slade G.D., Bair E., Gibson D.G., et al. Potential genetic risk factors for chronic TMD: Genetic associations from the OPPERA case control study. J. Pain. 2011;12:T92&#x2013;T101. doi: 10.1016/j.jpain.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2011.08.005</ArticleId><ArticleId IdType="pmc">PMC3268684</ArticleId><ArticleId IdType="pubmed">22074755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y.J., Jiang J.R., Jin S.Q. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis. Cephalalgia. 2017;37:592&#x2013;598. doi: 10.1177/0333102416649758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102416649758</ArticleId><ArticleId IdType="pubmed">27154995</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T., You Y., Joseph C., Mirzaei M., Klistorner A., Graham S.L., Gupta V. BDNF polymorphism: A review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis. 2018;9:523&#x2013;536. doi: 10.14336/AD.2017.0717.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2017.0717</ArticleId><ArticleId IdType="pmc">PMC5988606</ArticleId><ArticleId IdType="pubmed">29896439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottmann K., Mittmann T., Lessmann V. BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp. Brain Res. 2009;199:203&#x2013;234. doi: 10.1007/s00221-009-1994-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-009-1994-z</ArticleId><ArticleId IdType="pubmed">19777221</ArticleId></ArticleIdList></Reference><Reference><Citation>Latremoliere A., Woolf C.J. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J. Pain. 2009;10:895&#x2013;926. doi: 10.1016/j.jpain.2009.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2009.06.012</ArticleId><ArticleId IdType="pmc">PMC2750819</ArticleId><ArticleId IdType="pubmed">19712899</ArticleId></ArticleIdList></Reference><Reference><Citation>Minuzzi L.G., Seelaender M., Silva B.S.A., Cunha E.D.B.B., Deus M.C., Vasconcellos F.T.F., Marqueze L.F.B., Gadotti A.C., Baena C.P., Pereira T., et al. COVID-19 outcome relates with circulating BDNF, according to patient adiposity and age. Front. Nutr. 2021;8:784429. doi: 10.3389/fnut.2021.784429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.784429</ArticleId><ArticleId IdType="pmc">PMC8704131</ArticleId><ArticleId IdType="pubmed">34957187</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X., Ding M., Xuan J.F., Xing J.X., Pang H., Yao J., Wu X., Wang B.J. Effects of HTR1B 3&#x2019; region polymorphisms and functional regions on gene expression regulation. BMC Genet. 2020;21:79. doi: 10.1186/s12863-020-00886-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12863-020-00886-8</ArticleId><ArticleId IdType="pmc">PMC7372893</ArticleId><ArticleId IdType="pubmed">32689951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar R.P. Warriors, Worriers, and COVID-19: An Exploratory Study of the Catechol O-Methyltransferase Val158Met Polymorphism Across Populations. Cureus. 2020;12:e10103. doi: 10.7759/cureus.10103.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10103</ArticleId><ArticleId IdType="pmc">PMC7456627</ArticleId><ArticleId IdType="pubmed">32879833</ArticleId></ArticleIdList></Reference><Reference><Citation>Dro&#x17c;d&#x17c;al S., Rosik J., Lechowicz K., Machaj F., Szostak B., Majewski P., Rotter I., Kotfis K. COVID-19: Pain management in patients with SARS-CoV-2 Infection: Molecular mechanisms, challenges, and perspectives. Brain Sci. 2020;10:465. doi: 10.3390/brainsci10070465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10070465</ArticleId><ArticleId IdType="pmc">PMC7407489</ArticleId><ArticleId IdType="pubmed">32698378</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Del Gaudio A., Vittori A., Bimonte S., Del Prete P., Forte C.A., Cuomo A., De Blasio E. COVID-Pain: Acute and late-onset painful clinical manifestations in COVID-19: Molecular mechanisms and research perspectives. J. Pain Res. 2021;14:2403&#x2013;2412. doi: 10.2147/JPR.S313978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S313978</ArticleId><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S., Cohen M., Barke A., Korwisi B., Rief W., Treede R.D., IASP Taskforce for the Classification of Chronic Pain The IASP classification of chronic pain for ICD-11: Chronic secondary musculoskeletal pain. Pain. 2019;160:77&#x2013;82. doi: 10.1097/j.pain.0000000000001389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001389</ArticleId><ArticleId IdType="pubmed">30586074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer T.G., Neblett R., Cohen H., Howard K.J., Choi Y.H., Williams M.J., Perez Y., Gatchel R.J. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12:276&#x2013;285. doi: 10.1111/j.1533-2500.2011.00493.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1533-2500.2011.00493.x</ArticleId><ArticleId IdType="pmc">PMC3248986</ArticleId><ArticleId IdType="pubmed">21951710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.I., Smith B.H., Torrance N., Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J. Pain. 2005;6:149&#x2013;158. doi: 10.1016/j.jpain.2004.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2004.11.007</ArticleId><ArticleId IdType="pubmed">15772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Campayo J., Rodero B., Alda M., Sobradiel N., Montero J., Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med. Clin. 2008;131:487&#x2013;492. doi: 10.1157/13127277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13127277</ArticleId><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Woby S.R., Roach N.K., Urmston M., Watson P.J. Psychometric properties of the TSK-11: A shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005;117:137&#x2013;144. doi: 10.1016/j.pain.2005.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.05.029</ArticleId><ArticleId IdType="pubmed">16055269</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann-Lingen C., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale Deutsche Version (HADS-D) Verlag Hans Huber; Bern, Germany: 2011.</Citation></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Wen L., Shen X., Zhang H. Effects of the OPRM1 A118G polymorphism (rs1799971) on opioid analgesia in cancer pain: A Systematic review and meta-analysis. Clin. J. Pain. 2019;35:77&#x2013;86. doi: 10.1097/AJP.0000000000000636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0000000000000636</ArticleId><ArticleId IdType="pubmed">30028366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc. Natl. Acad. Sci. USA. 1998;95:9608&#x2013;9613. doi: 10.1073/pnas.95.16.9608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.16.9608</ArticleId><ArticleId IdType="pmc">PMC21386</ArticleId><ArticleId IdType="pubmed">9689128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999;51:593&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581325</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins L.R., Mayer D.J. Organization of endogenous opiate and non-opiate pain control systems. Science. 1982;216:1185&#x2013;1192. doi: 10.1126/science.6281891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6281891</ArticleId><ArticleId IdType="pubmed">6281891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholl B.I., Holliday K.L., Macfarlane G.J., Thomson W., Davies K.A., O&#x2019;Neill T.W., Bartfai G., Boonen S., Casanueva F., Finn J.D., et al. No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann. Rheum. Dis. 2010;69:2009&#x2013;2012. doi: 10.1136/ard.2009.126086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.126086</ArticleId><ArticleId IdType="pubmed">20570835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen K., Pettersen E., Stovner L.J., Skorpen F., Zwart J.A. No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene: The HUNT study. BMC Musculoskelet. Disord. 2006;7:40. doi: 10.1186/1471-2474-7-40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-7-40</ArticleId><ArticleId IdType="pmc">PMC1524765</ArticleId><ArticleId IdType="pubmed">16674809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.H., Choi S.J., Ji J.D., Song G.G. Candidate gene studies of fibromyalgia: A systematic review and meta-analysis. Rheumatol. Int. 2012;32:417&#x2013;426. doi: 10.1007/s00296-010-1678-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-010-1678-9</ArticleId><ArticleId IdType="pubmed">21120487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilova N., Soprun L., Lukashenko M., Ryabkova V., Fedotkina T.V., Churilov L.P., Shoenfeld Y. New Clinical phenotype of the Post-COVID syndrome: Fibromyalgia and joint hypermobility condition. Pathophysiology. 2022;29:24&#x2013;29. doi: 10.3390/pathophysiology29010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType="pmc">PMC8954589</ArticleId><ArticleId IdType="pubmed">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Ambite-Quesada S., Gil-Crujera A., Cigar&#xe1;n-M&#xe9;ndez M., Pe&#xf1;acoba-Puente C. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. J. Pain. 2012;13:1068&#x2013;1074. doi: 10.1016/j.jpain.2012.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.08.001</ArticleId><ArticleId IdType="pubmed">23025981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada A.S., Antunes F.T.T., Ferraz C., de Souza A.H., Simon D. The genetic influence of the brain-derived neurotrophic factor Val66Met polymorphism in chronic low back pain. Adv. Rheumatol. 2021;61:24. doi: 10.1186/s42358-021-00183-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-021-00183-7</ArticleId><ArticleId IdType="pubmed">33980293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol. Psychiatry. 2008;64:527&#x2013;532. doi: 10.1016/j.biopsych.2008.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.05.005</ArticleId><ArticleId IdType="pmc">PMC2597158</ArticleId><ArticleId IdType="pubmed">18571629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Yang M., Li P., Cao D., Gong D., Lv J., Pu L., Huang S., Liang Y. A meta-analysis of 5-Hydroxytryptamine receptor 1B polymorphisms with risk of major depressive disorder and suicidal behavior. Front. Psychiatry. 2021;12:696655. doi: 10.3389/fpsyt.2021.696655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.696655</ArticleId><ArticleId IdType="pmc">PMC8311000</ArticleId><ArticleId IdType="pubmed">34322042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>